VALPIP 100MG INJECTION

Formulation:Sodium Valproate 100 mg/ml

Use For: VALPIP 100 mg Injection contains Sodium Valproate, an antiepileptic and mood-stabilizing agent used in the treatment of various seizure disorders and certain psychiatric conditions. It is commonly administered in emergency or hospital settings when oral administration is not possible. Sodium Valproate works by increasing the levels of gamma-aminobutyric acid (GABA) in the brain, a neurotransmitter that helps to calm nerve activity, thereby reducing seizure frequency. VALPIP 100 mg Injection is effective in treating generalized seizures, including absence, myoclonic, and tonic-clonic seizures. It is also used in acute manic episodes associated with bipolar disorder and may be given to prevent seizures during or after neurosurgery. The injection is administered intravenously under medical supervision, with dosage adjusted based on the patient’s condition. Patients receiving VALPIP should be monitored for liver function, platelet count, and signs of toxicity. Caution is advised in children and those with liver problems.

✅ VALPIP 100MG INJECTION (Sodium Valproate 100 mg/ml)

🔹 Product Overview:
VALPIP 100MG Injection contains Sodium Valproate 100 mg/ml, a widely used anticonvulsant and mood-stabilizing agent. It is indicated for the treatment of various types of seizures, acute manic episodes associated with bipolar disorder, and as a supportive therapy in epilepsy. Administered intravenously, VALPIP offers rapid onset of action, making it suitable in emergency settings or when oral administration is not feasible. It helps stabilize electrical activity in the brain by increasing GABA (gamma-aminobutyric acid) levels, a neurotransmitter that calms nerve activity.

🔹 Therapeutic Uses:

Epilepsy (generalized, partial, and mixed seizures)
Status epilepticus
Acute mania in bipolar disorder
Seizure prophylaxis during neurosurgery or trauma
Migraine prophylaxis (off-label use)
When oral dosing is not possible due to unconsciousness or surgery

🔹 Mechanism of Action:
Sodium Valproate increases the availability of GABA in the brain by inhibiting GABA transaminase and possibly by increasing GABA synthesis. This results in stabilization of neuronal activity and suppression of abnormal electrical impulses in the brain. It also modulates sodium and calcium channels, contributing to its anticonvulsant properties.

🔹 Advantages:

Rapid control of seizures in emergency situations
Useful alternative when oral administration is not suitable
Broad-spectrum antiepileptic activity
Also effective for acute mania and bipolar disorders
Stabilizes mood in neuropsychiatric patients
WHO-recommended therapy for epilepsy management

🔹 For PCD Pharma Franchise:

Monopoly rights with region-wise exclusivity
Attractive injection vial packaging
Competitive MRPs with high-profit margins
Full marketing support (visual aids, samples, LBLs)
Promotional tools for neuropsychiatric range
Prompt delivery and stock backup

🔹 For Third-Party Manufacturing:

WHO-GMP certified injectable facilities
Customized batch sizes and packaging
High purity formulation with sterility assurance
Compliance with all regulatory norms
Private labeling and export support
Stability-tested sterile injectable manufacturing

VALPIP 100MG Injection is an effective antiepileptic and mood stabilizer for both emergency neurological management and supportive care in seizure control. With its intravenous delivery system, it acts rapidly to bring immediate symptom relief, particularly valuable in hospitals, ICUs, and during pre- or post-surgical care. It is also widely used in neuropsychiatric centers to manage acute manic states in bipolar patients.

🔹 Uses:

Epilepsy management
Status epilepticus treatment
Bipolar disorder (acute mania)
Seizure prevention during neurosurgical procedures
Emergency seizure control when oral route unavailable

🔹 Benefits:

Fast-acting IV administration
Covers wide spectrum of seizure types
Supports neurological stability in critical care
Effective for psychiatric emergencies (mania, agitation)

🔹 Side Effects:
Possible side effects may include nausea, vomiting, dizziness, tremors, elevated liver enzymes, thrombocytopenia, or pancreatitis. Liver function and blood counts should be monitored, especially during long-term use. Contraindicated in patients with hepatic disease.

KEYWORDS

VALPIP Injection, Sodium Valproate 100mg, anticonvulsant injection, seizure control, IV sodium valproate, epilepsy injection, mood stabilizer IV, emergency seizure treatment, antiepileptic medicine, GABA enhancer, generalized seizures, absence seizure treatment, tonic-clonic seizures, myoclonic seizure control, bipolar disorder injection, acute mania control, neurosurgery seizure prevention, IV antiepileptic, sodium valproate use, epilepsy emergency care, injectable valproate, CNS stabilizer, psychiatric IV medicine, brain calming injection, epilepsy in hospital, seizure prevention injection, mood episode control, fast-acting seizure medicine, hospital use valproate, valproate IV dose.Sodium Valproate injection, VALPIP 100mg injection, anticonvulsant injection PCD, neuro injection for epilepsy, epilepsy injection for franchise, IV Sodium Valproate manufacturers, emergency seizure control injection, bipolar mania injection treatment, WHO GMP Valproate injection, seizure emergency medicine IV, neuro ICU injection drug, sodium valproate injection exporters India, PCD pharma franchise for valproate, injectable antiepileptic drug, neurology injection pharma franchise, fast seizure relief injection, CNS injectable products PCD, pharma for epileptic disorder treatment, hospital use antiepileptic injection, neuropsychiatric injection third-party, emergency epilepsy drug manufacturers, acute mania injectable medicine, IV epilepsy medication PCD, sodium valproate injection third-party manufacturing, antiepileptic injectable WHO GMP, hospital supply neuro injection, emergency anticonvulsant pharma, valproate injection contract manufacturing, sodium valproate injection pharma suppliers, epilepsy injection for PCD pharma, injectable mood stabilizer manufacturers, DCGI approved injectable drugs, WHO certified injectable neuro products, neuro range PCD pharma injection, valproate injection 100mg/ml franchise, IV injection for acute seizures, neurosurgery seizure prophylaxis injection, mental health injection pharma, rapid seizure control injection, sodium valproate PCD range, anti-manic injection pharma distributor, neurological emergency drug franchise, high purity injectable sodium valproate, fast-action CNS injection India, epilepsy emergency injection supply, pharma contract manufacturing injectable drugs, CNS disorder injectable therapy, sodium valproate injection bulk suppliers, ICU injection sodium valproate, pharma injectable neuro support, India exporters of valproate injection, neuro injectable third-party suppliers, PCD pharma mood stabilizer injection, psychiatric care injection pharma, pharma for epilepsy support injection, WHO GMP CNS drug injection, DCGI approved CNS injectable medicine, injection for epileptic episodes, pharma franchise injectable mood stabilizer, injectable psychiatric medicine manufacturers, hospital injectable neurology range, anti-seizure injection pharma support, best injection for status epilepticus, sodium valproate for neuro hospitals, pharma franchise IV CNS injection, acute epilepsy IV medication, injection manufacturing for seizures, Indian pharma neuropsychiatry injection, neurology emergency PCD injection, Indian suppliers sodium valproate 100mg/ml, pharma injectable epilepsy franchise, pharma company for IV anticonvulsants, pharma for CNS emergencies injection, hospital-use CNS injectable range, IV epilepsy control pharma support, injection manufacturer WHO certified, Indian manufacturer of valproate injection, pharma injectable drug for epilepsy, third-party injectable neuropsychiatric drugs, injectable psychiatric range pharma company, fast-acting anti-seizure injection, CNS IV therapy pharma manufacturer, injection for psychiatric hospital use, pharma for emergency brain drug supply, injectable epilepsy management India, pharma for brain seizure injection, IV drug for bipolar disorder control, pharma partners for hospital neuro range, injection for ICU neurocare India, injectable drug for mental health support, emergency psychiatric drug pharma franchise, neurology hospital injection supply India, top neuro injectable brand franchise, injectable sodium valproate brand India, antiepileptic injection PCD support.sodium valproate IV injection PCD franchise, injectable antiepileptic drug suppliers, sodium valproate 100mg/ml IV use, hospital emergency seizure injection, ICU injectable anti-seizure drug, sodium valproate IV for status epilepticus, pharma injectable for bipolar mania, neuro PCD franchise injectable range, epilepsy care IV formulation suppliers, third-party injectable anticonvulsants India, IV sodium valproate DCGI approved, GMP certified injectable CNS products, seizure disorder IV injection manufacturers, contract manufacturing antiepileptic injections, epilepsy treatment injection pharma support, emergency injectable neuro care products, injectable psychotropic drug franchise India, top injectable epilepsy medication brand, sodium valproate 100 injection exporters, sodium valproate hospital use PCD, injectable sodium valproate CNS segment, mood stabilizer injection for bipolar PCD, fast-acting antiepileptic injection WHO GMP, CNS injectable neuro psychiatric treatment, pharma marketing IV valproate injection, injectable mood stabilizer sodium salt, valproate sodium injection pharma company, neuro range PCD pharma injectable franchise, epilepsy injectable medicine suppliers India, IV formulation for neurological emergencies, pharma franchise CNS injection range, injectable seizure prevention therapy, sodium valproate psychotropic drug injection, injectable sodium valproate pharma support, bipolar disorder injection treatment pharma, pharma for emergency IV sodium injection, rapid onset antiepileptic injectable India, WHO GMP injectable epilepsy franchise, high efficacy injectable anti-seizure pharma, injectable neurology support formulation, pharma exporter IV valproate salt injection, Indian injectable neurology care pharma, hospital neurology support injection franchise, sodium valproate injection 100mg/ml manufacturers, pharma for CNS emergency care injection, neurology department IV drug supply, ICU epilepsy injection third-party manufacturer, India injection franchise antiepileptic, sodium valproate IV vial pharma marketing, DCGI approved CNS injectable range, top injectable epilepsy pharma supplier India, injectable antiepileptic hospital formulation, injectable CNS stabilization treatment, pharma manufacturing injectable neuro psychiatry, GMP neuro injection contract manufacturing India, pharma for neurology injectable brands, IV epilepsy control sodium injection brand, antiepileptic injection marketing support, neuro specialty pharma for injectable products, hospital-use anti-seizure drug franchise India, Indian pharma contract manufacturing CNS injectables, pharma bulk supply sodium valproate injection, injectable brain stabilizer sodium salt, injectable medication for seizure emergency, IV sodium valproate for neuro hospitals, epilepsy crisis IV injection third-party, neurology injectable support range India, Indian injection pharma for epilepsy care, mood stabilizing injectable franchise supply, IV CNS drug franchise pharma distributors, sodium valproate hospital brand injectable, antiepileptic pharma contract manufacturer India, IV epilepsy injection pharma export support, Indian neuro injection suppliers WHO GMP, pharma injectable epilepsy seizure range, hospital CNS injectable pharma product, pharma franchise for neurology injections, emergency seizure control injection pharma, sodium valproate injectable bulk exporter India, neuro injectable PCD marketing company, IV valproate injection for seizure prevention, injectable sodium valproate GMP pharma firm, pharma supply hospital neurology range India, injectable drug for psychiatric ICU use, top CNS injectable pharma franchise India, Indian pharma injectable epilepsy treatment, neuropsychiatry injection suppliers PCD, CNS injectable neuro care drug suppliers, sodium valproate injectable third-party India, pharma exporters sodium-based CNS injectables, injectable psych drug pharma PCD model, pharma contract manufacturer injectable valproate, neuro hospital injectable support franchise, pharma injectable neuro formulation exporters, pharma injectable neurology drug listing, best injectable epilepsy drug WHO certified, injectable antiepileptic combination range, IV sodium valproate mood stabilizer franchise, hospital CNS injection PCD marketing tools, sodium valproate injection 100 mg/ml vial pharma, pharma for brain seizure control injectable, antiepileptic CNS injection contract manufacturing, pharma company for injectable neuro care range, IV epilepsy injection pharma company India, fast-action injectable for psychiatric emergency, injectable medicine for bipolar rage India, valproate injectable CNS pharma company, pharma injectable for epilepsy in ICU settings, Indian pharma injectable psychiatric product suppliers, IV valproate solution PCD pharma company, hospital neuro injection pharma partner India, emergency psych drug franchise support, neuro injectable support brand marketing India.